News – Page 102 – Endpoints News

Updated: Viridian reveals first Phase 3 eye disease data in bid to compete with Tepezza

8 months ago

Centessa to take narcolepsy drug into Phase 2 after no sign of side effects that doomed earlier competitor

8 months ago

Exclusive: Bain scoops up $3B for fourth life sciences fund after handful of M&A deals

8 months ago

Roivant unveils its next deal, hoping for TL1A-sized potential from a shelved Bayer lung disease therapy

8 months ago

Bayer's treatment for menopause symptoms hits primary endpoints in third late-stage trial

8 months ago

FDA advisors question whether Iterum's application for a UTI antibacterial is restrictive enough

8 months ago

House passes Biosecure Act, sending Chinese biotech ban to Senate

8 months ago

A General Catalyst-backed startup raised $38M to help workers buy health coverage on their own

8 months ago

#WCLC24 roundup: ArriVent thinks its drug can fill Tagrisso's gaps; Boehringer, Bayer's data in HER2-mutated lung ...

8 months ago

CDER chief on inspection backlog: 2025 will be a 'crucial year'

8 months ago

GSK says long-acting asthma hopeful significantly cut attacks

8 months ago

AstraZeneca, Gilead detail TROP2 ADC data in lung cancer as they search for new ways forward

8 months ago

Zealand’s GLP-1/GLP-2 drug bounces back with new Phase 1b data

8 months ago

#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody

8 months ago

AstraZeneca's monoclonal antibody misses primary endpoint in mid-stage trial in COPD

8 months ago

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

8 months ago

Bicycle Therapeutics makes an early case for its Padcev competitor: #ESMO24

8 months ago

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

8 months ago

Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy

8 months ago

Lilly again hires from within for CFO post, elevating 23-year company veteran

8 months ago

MBX seeks $114M IPO to compete with Ascendis and get a long-acting GLP-1/GIP prodrug into the clinic

8 months ago

Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer

8 months ago

Terns’ oral GLP-1 passes Phase 1 test with promising weight loss after one month

8 months ago

Eli Lilly invests in Superluminal's $120M Series A round as AI-focused startups eye the clinic

8 months ago

First page Previous page 99 100 101102103 104 105 Next page Last page